Work

Use of epigenetic inhibitor screen to identify HDAC1/2 inhibitor as a pro-differentiation therapy in colorectal cancer.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.e15538

Authors: Pornlada Likasitwatanakul, Zhixin Li, Sandor Spisak, Paul Doan, Pratyusha Bala, Priscilla Liow, Malvina Papanastasiou, Jun Qi, Nilay S. Sethi

Institutions: University of Minnesota, Dana-Farber Cancer Institute, Hungarian Academy of Sciences, HUN-REN Research Centre for Natural Sciences, Broad Institute

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Harvard Digestive Diseases Center, Harvard University

OpenAlex ID: W4399880063

Cites:

Cited by:

Related to: 10